v3.20.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating Expenses:        
Research and development expenses $ 1,847,178 $ 864,280 $ 3,789,800 $ 2,761,630
General and administrative expenses 1,491,173 881,462 3,667,588 3,392,388
Total Operating Expenses 3,338,351 1,745,742 7,457,388 6,154,018
Loss From Operations (3,338,351) (1,745,742) (7,457,388) (6,154,018)
Other Income (Expense)        
Interest income 2,532 29,859 31,146 62,840
Other income 2,500
Warrant modification expense (441,763)
Total other income (expense) 2,532 29,859 33,646 (378,923)
Loss Before Provision For Income Taxes (3,335,819) (1,715,883) (7,423,742) (6,532,941)
Provision for income taxes
Net Loss $ (3,335,819) $ (1,715,883) $ (7,423,742) $ (6,532,941)
Net loss per share, basic and diluted $ (0.24) $ (0.17) $ (0.63) $ (0.68)
Weighted average shares, basic and diluted 13,646,153 10,252,458 11,825,179 9,599,211

Source